Literature DB >> 22659246

Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation.

Stefan M Gold1, Manda V Sasidhar, Venu Lagishetty, Rory D Spence, Elizabeth Umeda, Marina O Ziehn, Thorsten Krieger, Karl-Heinz Schulz, Christoph Heesen, Martin Hewison, Rhonda R Voskuhl.   

Abstract

CONTEXT: Glucocorticoids (GC) are powerful endogenous and therapeutic modulators of inflammation and play a critical role for controlling autoimmunity. GC resistance can be seen in patients with cell-mediated autoimmune disorders, but it is unknown whether this represents a stable trait or a state.
OBJECTIVE: The objective of the study was to determine whether GC resistance of T cell responses is dynamically regulated in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS).
DESIGN: This was a translational observational study. PATIENTS AND ANIMALS: EAE was induced in C57BL/6 mice. A cross-sectional sample of 25 patients with relapsing-remitting MS was included as well as four MS patients during pregnancy and postpartum. MAIN OUTCOME MEASURES: Outcome measures included GC sensitivity of T cell proliferation and GC-mediated apoptosis.
RESULTS: GC resistance was seen in both autoantigen-specific and nonspecific responses of T cells obtained from mice with EAE. GC resistance preceded clinical symptoms and central nervous system infiltration of immune cells. T cells obtained during EAE were resistant to GC-induced apoptosis, and this was linked to down-regulation of GC receptor-α expression. GC resistance in T cells was also seen in MS patients with radiological evidence for ongoing inflammation. GC resistance was absent in the MS patients during pregnancy, when relapse risk is decreased, but recurred postpartum, a time of increased relapse risk.
CONCLUSIONS: These data demonstrate that GC resistance during autoimmune neuroinflammation is dynamically regulated. This has implications for the timing of steroid treatments and provides a putative pathway to explain the observed association between psychological stress and exacerbation of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22659246      PMCID: PMC3410265          DOI: 10.1210/jc.2012-1294

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis.

Authors:  A Flügel; T Berkowicz; T Ritter; M Labeur; D E Jenne; Z Li; J W Ellwart; M Willem; H Lassmann; H Wekerle
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

2.  Social stress induces glucocorticoid resistance in macrophages.

Authors:  J L Stark; R Avitsur; D A Padgett; K A Campbell; F M Beck; J F Sheridan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

Review 3.  Autoaggressive effector T cells in the course of experimental autoimmune encephalomyelitis visualized in the light of two-photon microscopy.

Authors:  Alexander Flügel; Francesca Odoardi; Mikhail Nosov; Naoto Kawakami
Journal:  J Neuroimmunol       Date:  2007-10-31       Impact factor: 3.478

4.  Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat.

Authors:  A Stefferl; C Linington; F Holsboer; J M Reul
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

5.  Life stress and diminished expression of genes encoding glucocorticoid receptor and beta2-adrenergic receptor in children with asthma.

Authors:  Gregory E Miller; Edith Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

6.  Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.

Authors:  A Stefferl; M K Storch; C Linington; C Stadelmann; H Lassmann; T Pohl; F Holsboer; F J Tilders; J M Reul
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

7.  Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

Authors:  J C Webster; R H Oakley; C M Jewell; J A Cidlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

8.  Glucocorticoid-induced apoptosis in human decidua: a novel role for 11beta-hydroxysteroid dehydrogenase in late gestation.

Authors:  Junny Chan; Elizabeth H Rabbitt; Barbara A Innes; Judith N Bulmer; Paul M Stewart; Mark D Kilby; Martin Hewison
Journal:  J Endocrinol       Date:  2007-10       Impact factor: 4.286

9.  The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients.

Authors:  P Sliwinska-Stanczyk; J Pazdur; M Ziolkowska; J Jaworski; E Kaminska-Tchorzewska; J K Lacki
Journal:  Scand J Rheumatol       Date:  2007 May-Jun       Impact factor: 3.641

10.  Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.

Authors:  Anja Fischer; Christian Otte; Thorsten Krieger; Robert A Nicholls; Schulamith Krüger; Kristin J Ziegler; Karl-Heinz Schulz; Christoph Heesen; Stefan M Gold
Journal:  Psychoneuroendocrinology       Date:  2012-03-27       Impact factor: 4.905

View more
  14 in total

1.  Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy.

Authors:  Jan Broder Engler; Nina Kursawe; María Emilia Solano; Kostas Patas; Sabine Wehrmann; Nina Heckmann; Fred Lühder; Holger M Reichardt; Petra Clara Arck; Stefan M Gold; Manuel A Friese
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

2.  Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.

Authors:  P O Barros; T Cassano; J Hygino; T B Ferreira; N Centurião; T M Kasahara; R M Andrade; U C Linhares; A F B Andrade; C C F Vasconcelos; R Alvarenga; R Marignier; C A M Bento
Journal:  Clin Exp Immunol       Date:  2015-12-01       Impact factor: 4.330

3.  Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.

Authors:  Ana Cristina Wing; Joana Hygino; Thais B Ferreira; Taissa M Kasahara; Priscila O Barros; Priscila M Sacramento; Regis M Andrade; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Claudia Cristina Vasconcelos; Regina Alvarenga; Cleonice A M Bento
Journal:  Immunology       Date:  2015-12-02       Impact factor: 7.397

Review 4.  Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Semin Immunopathol       Date:  2016-08-08       Impact factor: 9.623

5.  Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Priscila O Barros; Bruna Teixeira; Taissa M Kasahara; Ulisses C Linhares; Lana Márcia F Lopes; Claudia Cristina F Vasconcelos; Regina Alvarenga; Ana Cristina Wing; Regis M Andrade; Arnaldo F B Andrade; Cleonice A M Bento
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

6.  HIV and symptoms of depression are independently associated with impaired glucocorticoid signaling.

Authors:  Mandakh Bekhbat; C Christina Mehta; Sean D Kelly; Aimee Vester; Ighovwerha Ofotokun; Jennifer Felger; Gina Wingood; Kathryn Anastos; Deborah R Gustafson; Seble Kassaye; Joel Milam; Bradley Aouizerat; Kathleen Weber; Elizabeth T Golub; Michelle Floris Moore; Ralph Diclemente; Margaret Fischl; Mirjam-Colette Kempf; Pauline Maki; Gretchen N Neigh
Journal:  Psychoneuroendocrinology       Date:  2018-06-18       Impact factor: 4.905

7.  MANF Is Neuroprotective in Early Stages of EAE, and Elevated in Spinal White Matter by Treatment With Dexamethasone.

Authors:  Jinhan Nam; Tapani K Koppinen; Merja H Voutilainen
Journal:  Front Cell Neurosci       Date:  2021-07-07       Impact factor: 5.505

8.  Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients.

Authors:  Tian Song; Haoxiao Chang; Li Du; Linlin Yin; Fudong Shi; Xinghu Zhang
Journal:  Neurol Sci       Date:  2020-04-10       Impact factor: 3.307

9.  The Function of the Hypothalamic-Pituitary-Adrenal Axis During Experimental Autoimmune Encephalomyelitis: Involvement of Oxidative Stress Mediators.

Authors:  Svetlana Trifunovic; Ivana Stevanovic; Ana Milosevic; Natasa Ristic; Marija Janjic; Ivana Bjelobaba; Danijela Savic; Iva Bozic; Marija Jakovljevic; Katarina Tesovic; Danijela Laketa; Irena Lavrnja
Journal:  Front Neurosci       Date:  2021-06-17       Impact factor: 4.677

Review 10.  Disease- and treatment-associated acquired glucocorticoid resistance.

Authors:  Legh Wilkinson; Nicolette J D Verhoog; Ann Louw
Journal:  Endocr Connect       Date:  2018-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.